A Study to Assess the Mass Balance and ADME of [14C]AZD5004 and the Absolute Bioavailability of AZD5004

Trial Identifier:	D7260C00010
Sponsor:	AstraZeneca
Collaborator:	Quotient Sciences Limited
Start Date:	March 2025
Primary Completion Date:	May 2025
Study Completion Date:	May 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	Ruddington, GB, NG11 6JS

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.